1. Início
  2. Hospital das Clínicas da Faculdade de Medicina - HC
  3. Instituto Central - HC/ICHC
  4. Artigos e Materiais de Revistas Científicas - HC/ICHC
Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/41681
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSANTOS, Alexandra Gomes dos-
dc.contributor.authorCARVALHO, Rodolfo Figueiredo de-
dc.contributor.authorMORAIS, Artur Nobrega Lima Rodrigues de-
dc.contributor.authorSILVA, Tamires Martins-
dc.contributor.authorBAYLAO, Victor Matheus Ribeiro-
dc.contributor.authorAZEVEDO, Mayara-
dc.contributor.authorOLIVEIRA, Adilson J. M. de-
dc.date.accessioned2021-08-13T15:17:25Z-
dc.date.available2021-08-13T15:17:25Z-
dc.date.issued2021-
dc.identifier.citationCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, v.163, article ID 103372, 7p, 2021-
dc.identifier.issn1040-8428-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/41681-
dc.description.abstractGliomas are the main type of intra-axial primary brain tumors. We performed a systematic review of studies on the neutrophil-to-lymphocyte ratio (NLR) and its role in the prognosis of patients with gliomas. An English-language literature-based search, using the PubMed and Biblioteca Virtual em Saude databases, was conducted for papers published until May 2, 2020. The quality of the selected articles was stratified using the Newcastle-Ottawa scale's criteria. We found 137 publications for a query string. After applying the inclusion criteria, 13 articles were selected. Seven studies assessed overall survival and found high NLR values associated with poor overall survival. Six studies approached the issue of tumor grading and differential diagnosis and demonstrated that patients with high NLR values were diagnosed with high-grade gliomas. NLR is a low-cost method and an effective prognostic factor associated with tumor grading and OS in patients with gliomas.eng
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE INCeng
dc.relation.ispartofCritical Reviews in Oncology Hematology-
dc.rightsrestrictedAccesseng
dc.subjectGliomaeng
dc.subjectGlioblastomaeng
dc.subjectSurvivaleng
dc.subjectMortalityeng
dc.subjectOutcomeeng
dc.subjectPrognosiseng
dc.subjectGradingeng
dc.subjectNeutrophil-to-lymphocyte ratioeng
dc.subject.othercentral-nervous-systemeng
dc.subject.otherrecurrent glioblastomaeng
dc.subject.otherpreoperative neutrophileng
dc.subject.otheradjuvant temozolomideeng
dc.subject.otherinflammatory markerseng
dc.subject.otheropen-labeleng
dc.subject.othersurvivaleng
dc.subject.otherresectioneng
dc.subject.otherbraineng
dc.subject.otherprognosiseng
dc.titleRole of neutrophil-lymphocyte ratio as a predictive factor of glioma tumor grade: A systematic revieweng
dc.typearticleeng
dc.rights.holderCopyright ELSEVIER SCIENCE INCeng
dc.identifier.doi10.1016/j.critrevonc.2021.103372-
dc.identifier.pmid34062242-
dc.subject.wosOncologyeng
dc.subject.wosHematologyeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalCARVALHO, Rodolfo Figueiredo de:Hosp Ernesto Dornelles, Porto Alegre, RS, Brazil-
hcfmusp.author.externalAZEVEDO, Mayara:Univ Fed ABC, Fac Ciencias, Sao Paulo, Brazil-
hcfmusp.description.articlenumber103372-
hcfmusp.description.volume163-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000674448900010-
hcfmusp.origem.id2-s2.0-85108090046-
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAldape K, 2015, ACTA NEUROPATHOL, V129, P829, DOI 10.1007/s00401-015-1432-1eng
hcfmusp.relation.referenceAmankulor NM, 2017, GENE DEV, V31, P774, DOI 10.1101/gad.294991.116eng
hcfmusp.relation.reference[Anonymous], 2018, NEUROL RES, DOI 10.1080/01616412.2018.1497271eng
hcfmusp.relation.referenceAuezova R, 2019, CANCER MANAG RES, V11, P3227, DOI 10.2147/CMAR.S195754eng
hcfmusp.relation.referenceAuezova R, 2016, ONCOTARGETS THER, V9, P6111, DOI 10.2147/OTT.S113606eng
hcfmusp.relation.referenceBalana C, 2020, NEURO-ONCOLOGY, V22, P1851, DOI 10.1093/neuonc/noaa107eng
hcfmusp.relation.referenceBao YF, 2018, WORLD NEUROSURG, V119, pE710, DOI 10.1016/j.wneu.2018.07.252eng
hcfmusp.relation.referenceBigot F, 2017, EUR J CANCER, V84, P212, DOI 10.1016/j.ejca.2017.07.027eng
hcfmusp.relation.referenceBloch O, 2012, J NEUROSURG, V117, P1032, DOI 10.3171/2012.9.JNS12504eng
hcfmusp.relation.referenceBowen RC, 2017, ONCOTARGET, V8, P32171, DOI 10.18632/oncotarget.16291eng
hcfmusp.relation.referenceCataudella E, 2017, J AM GERIATR SOC, V65, P1796, DOI 10.1111/jgs.14894eng
hcfmusp.relation.referenceCheng HB, 2013, TUMOR BIOL, V34, P3555, DOI 10.1007/s13277-013-0934-5eng
hcfmusp.relation.referenceChinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345eng
hcfmusp.relation.referenceDolan RD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16955-5eng
hcfmusp.relation.referenceDong X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205704eng
hcfmusp.relation.referenceEthier JL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0794-1eng
hcfmusp.relation.referenceFatehi M, 2018, WORLD NEUROSURG, V120, pE511, DOI 10.1016/j.wneu.2018.08.114eng
hcfmusp.relation.referenceFossati G, 1999, ACTA NEUROPATHOL, V98, P349, DOI 10.1007/s004010051093eng
hcfmusp.relation.referenceGandhi P, 2018, INT J MOL CELL MED, V7, P111, DOI 10.22088/IJMCM.BUMS.7.2.111eng
hcfmusp.relation.referenceGilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573eng
hcfmusp.relation.referenceHe ZQ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.11.24eng
hcfmusp.relation.referenceHegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331eng
hcfmusp.relation.referenceHerrlinger U, 2019, LANCET, V393, P678, DOI 10.1016/S0140-6736(18)31791-4eng
hcfmusp.relation.referenceHuang ZX, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1549-2eng
hcfmusp.relation.referenceLacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190eng
hcfmusp.relation.referenceLei YY, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1686-5eng
hcfmusp.relation.referenceLokker NA, 2002, CANCER RES, V62, P3729eng
hcfmusp.relation.referenceLouis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4eng
hcfmusp.relation.referenceLouis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1eng
hcfmusp.relation.referenceLouis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171eng
hcfmusp.relation.referenceLOUIS DN, 1994, J NEUROPATH EXP NEUR, V53, P11, DOI 10.1097/00005072-199401000-00002eng
hcfmusp.relation.referenceLu VM, 2018, WORLD NEUROSURG, V115, P453, DOI 10.1016/j.wneu.2018.04.016eng
hcfmusp.relation.referenceLv YJ, 2019, CLIN NEUROL NEUROSUR, V181, P24, DOI 10.1016/j.clineuro.2019.03.017eng
hcfmusp.relation.referenceMalmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6eng
hcfmusp.relation.referenceMcGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536eng
hcfmusp.relation.referenceMitsuya K, 2017, J NEUROSURG, V127, P433, DOI 10.3171/2016.8.JNS16899eng
hcfmusp.relation.referenceMoher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873eng
hcfmusp.relation.referenceMukherjee S, 2020, CLIN NEUROL NEUROSUR, V188, DOI 10.1016/j.clineuro.2019.105568eng
hcfmusp.relation.referenceNobrega Lima Rodrigues de Morais A., 2021, NEUROSURG REVeng
hcfmusp.relation.referenceOppenlander ME, 2014, J NEUROSURG, V120, P846, DOI 10.3171/2013.12.JNS13184eng
hcfmusp.relation.referenceOstrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI 10.1093/neuonc/nov189eng
hcfmusp.relation.referencePark JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582eng
hcfmusp.relation.referencePerry JR, 2017, NEW ENGL J MED, V376, P1027, DOI 10.1056/NEJMoa1611977eng
hcfmusp.relation.referenceQuick J, 2014, J NEURO-ONCOL, V117, P365, DOI 10.1007/s11060-014-1397-2eng
hcfmusp.relation.referenceRich JN, 2001, CANCER RES, V61, P3556eng
hcfmusp.relation.referenceStupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7eng
hcfmusp.relation.referenceTao CY, 2017, BIOMARK MED, V11, P33, DOI 10.2217/bmm-2016-0187eng
hcfmusp.relation.referenceWang DP, 2020, CTS-CLIN TRANSL SCI, V13, P179, DOI 10.1111/cts.12700eng
hcfmusp.relation.referenceWang PF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00886eng
hcfmusp.relation.referenceWeller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8eng
hcfmusp.relation.referenceWeng YL, 2018, WORLD NEUROSURG, V118, pE137, DOI 10.1016/j.wneu.2018.06.142eng
hcfmusp.relation.referenceWu YY, 2019, ONCOTARGETS THER, V12, P11413, DOI 10.2147/OTT.S236598eng
hcfmusp.relation.referenceYan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710eng
hcfmusp.relation.referenceYang T, 2019, ONCOL LETT, V17, P2516, DOI 10.3892/ol.2018.9870eng
hcfmusp.relation.referenceZheng J, 2017, CELL PHYSIOL BIOCHEM, V44, P967, DOI 10.1159/000485396eng
hcfmusp.relation.referenceZheng S.H., 2018, J NEUROSURG, V129, P583, DOI [10.3171/2017.3.JNS161648, DOI 10.3171/2017.3.JNS161648]eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1879-0461-
hcfmusp.citation.scopus17-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/61
LIM/61 - Laboratório de Pesquisa em Cirurgia Torácica

Artigos e Materiais de Revistas Científicas - LIM/62
LIM/62 - Laboratório de Fisiopatologia Cirúrgica

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_SANTOS_Role_of_neutrophillymphocyte_ratio_as_a_predictive_factor_2021.PDF
  Restricted Access		publishedVersion (English)1.17 MBAdobe PDFView/Open Request a copy
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.